ReviewOncotarget2017

Breaking the crosstalk of the cellular tumorigenic network: Hypothesis for addressing resistances to targeted therapies in advanced NSCLC.

Stefan Langhammer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.